Nadia Amrani

3.3k citations

26 papers · 2.1k indexed · 1 hit paper · h-index 20

Molecular Biology top 5%
Genetics top 10%
Business and International Management top 1%
Plant Science
Cardiology and Cardiovascular Medicine

Co-authors: Allan Jacobson David A. Mangus Shubhendu Ghosh Matthew S. Sachs Robin Ganesan Stéphanie Kervestin Erik J. Sontheimer Michèle Minét
Topics: RNA and protein synthesis mechanisms (18 papers)CRISPR and Genetic Engineering (11 papers)RNA Research and Splicing (11 papers)
Cited by: Business and International Management Aging Molecular Biology
Journals: Nature Cell Nucleic Acids Research
Partner nations: United States France Canada

In The Last Decade

Nadia Amrani

26 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Broad-Spectrum Inhibitor of CRISPR-Cas9

2017 191 citations Lucas B. Harrington, Kevin Doxzen et al. Cell profile →

Peers

Countries citing papers authored by Nadia Amrani

Since Specialization

Citations

This map shows the geographic impact of Nadia Amrani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nadia Amrani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nadia Amrani more than expected).

Fields of papers citing papers by Nadia Amrani

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nadia Amrani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nadia Amrani. The network helps show where Nadia Amrani may publish in the future.

Co-authorship network of co-authors of Nadia Amrani

This figure shows the co-authorship network connecting the top 25 collaborators of Nadia Amrani. A scholar is included among the top collaborators of Nadia Amrani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nadia Amrani. Nadia Amrani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	CRISPR-Cas9-mediated genome editing delivered by a single AAV9 vector inhibits HSV-1 reactivation in a latent rabbit keratitis model 2024 ·Molecular Therapy — Methods & Clinical Development ·Nadia Amrani,Kevin Luk,(unknown),(unknown),Meltem Isik,Martina Donadoni,Anna Bellizzi,Kamel Khalili,Ilker K. Sariyer,Donna M. Neumann,Jennifer Gordon,Guo-Xiang Ruan	5
2	Self-delivering, chemically modified CRISPR RNAs for AAV co-delivery and genome editing in vivo 2023 ·Nucleic Acids Research ·(unknown),Karen Kelly,Jonathan Lee,Dimas Echeverria,David Cooper,(unknown),Nadia Amrani,Zexiang Chen,(unknown),(unknown),Gregory A. Newby,Jun Xie,David R. Liu,Guangping Gao,Scot A. Wolfe,Anastasia Khvorova,Jonathan K. Watts,Erik J. Sontheimer	10
3	Genome-wide detection and analysis of CRISPR-Cas off-targets 2021 ·Progress in molecular biology and translational science ·Tomás Rodríguez,(unknown),Henry Pratt,Pengpeng Liu,Nadia Amrani,Lihua Julie Zhu	11
4	An engineered ScCas9 with broad PAM range and high specificity and activity 2020 ·Nature Biotechnology ·Pranam Chatterjee,Noah Jakimo,Jooyoung Lee,Nadia Amrani,Tomás Rodríguez,(unknown),Emma Tysinger,Rui Qing,Shilei Hao,Erik J. Sontheimer,Joseph M. Jacobson	93
5	Publisher Correction: An engineered ScCas9 with broad PAM range and high specificity and activity 2020 ·Nature Biotechnology ·Pranam Chatterjee,Noah Jakimo,Jooyoung Lee,Nadia Amrani,Tomás Rodríguez,(unknown),Emma Tysinger,Rui Qing,Shilei Hao,Erik J. Sontheimer,Joseph M. Jacobson	2
6	Bridge Helix of Cas9 Modulates Target DNA Cleavage and Mismatch Tolerance 2019 ·Biochemistry ·Kesavan Babu,Nadia Amrani,Wei Jiang,S.D. Yogesha,Ruby H.N. Nguyen,Peter Z. Qin,Rakhi Rajan	33
7	Structures of Neisseria meningitidis Cas9 Complexes in Catalytically Poised and Anti-CRISPR-Inhibited States 2019 ·Molecular Cell ·Wei Sun,Jing Yang,Zhi Cheng,Nadia Amrani,Chao Liu,Kangkang Wang,Raed Ibraheim,Alireza Edraki,Xue Huang,Min Wang,Jiuyu Wang,Liang Liu,Gang Sheng,Yanhua Yang,Jizhong Lou,Erik J. Sontheimer,Yanli Wang	80
8	Potent Cas9 Inhibition in Bacterial and Human Cells by AcrIIC4 and AcrIIC5 Anti-CRISPR Proteins 2018 ·mBio ·Jooyoung Lee,Aamir Mir,Alireza Edraki,Bianca Garcı́a,Nadia Amrani,(unknown),Ildar Gainetdinov,April Pawluk,Raed Ibraheim,Xin D. Gao,Pengpeng Liu,Alan R. Davidson,Karen L. Maxwell,Erik J. Sontheimer	79
9	NmeCas9 is an intrinsically high-fidelity genome-editing platform 2018 ·Genome biology ·Nadia Amrani,Xin D. Gao,Pengpeng Liu,Alireza Edraki,Aamir Mir,Raed Ibraheim,Ankit Gupta,Kanae Sasaki,Tong Wu,Paul D. Donohoue,Alexander Settle,(unknown),(unknown),Chris Fuller,Peter Cameron,Thomas G. Fazzio,Lihua Julie Zhu,Scot A. Wolfe,Erik J. Sontheimer	96
10	All-in-one adeno-associated virus delivery and genome editing by Neisseria meningitidis Cas9 in vivo 2018 ·Genome biology ·Raed Ibraheim,Chun‐Qing Song,Aamir Mir,Nadia Amrani,Wen Xue,Erik J. Sontheimer	92
11	Orthogonal Cas9–Cas9 chimeras provide a versatile platform for genome editing 2018 ·Nature Communications ·Mehmet Fatih Bolukbasi,Pengpeng Liu,Kevin Luk,(unknown),Ankit Gupta,Nadia Amrani,Erik J. Sontheimer,Lihua Julie Zhu,Scot A. Wolfe	23
12	A Broad-Spectrum Inhibitor of CRISPR-Cas9breakdown → 2017 ·Cell ·Lucas B. Harrington,Kevin Doxzen,Enbo Ma,Junjie Liu,Gavin J. Knott,Alireza Edraki,Bianca Garcı́a,Nadia Amrani,Janice S. Chen,Joshua C. Cofsky,Philip J. Kranzusch,Erik J. Sontheimer,Alan R. Davidson,Karen L. Maxwell,Jennifer A. Doudna	191
13	Translational competence of ribosomes released from a premature termination codon is modulated by NMD factors 2010 ·RNA ·Shubhendu Ghosh,Robin Ganesan,Nadia Amrani,Allan Jacobson	39
14	Qualitative and Quantitative Assessment of the Activity of the Yeast Nonsense-Mediated mRNA Decay Pathway 2008 ·Methods in enzymology on CD-ROM/Methods in enzymology ·Feng He,Nadia Amrani,Marcus Johansson,Allan Jacobson	24
15	Translation factors promote the formation of two states of the closed-loop mRNP 2008 ·Nature ·Nadia Amrani,Shubhendu Ghosh,David A. Mangus,Allan Jacobson	155
16	The Use of Fungal In Vitro Systems for Studying Translational Regulation 2007 ·Methods in enzymology on CD-ROM/Methods in enzymology ·Cheng Wu,Nadia Amrani,Allan Jacobson,Matthew S. Sachs	39
17	Aberrant termination triggers nonsense-mediated mRNA decay 2006 ·Biochemical Society Transactions ·Nadia Amrani,Shuyun Dong,Fei He,Robin Ganesan,(unknown),Stéphanie Kervestin,(unknown),David A. Mangus,Phyllis Spatrick,(unknown)	59
18	Aberrant termination triggers nonsense-mediated mRNA decay 2005 ·Biochemical Society Transactions ·Shuyun Dong,Nadia Amrani,Fei He,Robin Ganesan,(unknown),Stéphanie Kervestin,(unknown),David A. Mangus,Phyllis Spatrick,(unknown)	3
19	PCF11 Encodes a Third Protein Component of Yeast Cleavage and Polyadenylation Factor I 1997 ·Molecular and Cellular Biology ·Nadia Amrani,Michèle Minét,Françoise Wyers,Marie‐Elisabeth Dufour,Lawrence P. Aggerbeck,F. Lacroute	84
20	Mutations inSTS1 suppress the defect in 3′ mRNA processing caused by therna15-2 mutation inSaccharomyces cerevisiae 1996 ·Molecular and General Genetics MGG ·Nadia Amrani,Marie‐Elisabeth Dufour,Nathalie Bonneaud,F. Lacroute	21

About Nadia Amrani

Nadia Amrani is a scholar working on Molecular Biology, Insect Science and Biomaterials, having authored 26 papers that have together received 2.1k indexed citations. Recurring topics across this work include RNA and protein synthesis mechanisms (18 papers), CRISPR and Genetic Engineering (11 papers) and RNA Research and Splicing (11 papers). The work is most often cited by research in Business and International Management (131 citations), Aging (59 citations) and Molecular Biology (1.9k citations). Nadia Amrani has collaborated with scholars based in United States, France and Canada. Frequent co-authors include Allan Jacobson, David A. Mangus, Shubhendu Ghosh, Matthew S. Sachs, Robin Ganesan, Stéphanie Kervestin, Erik J. Sontheimer, Michèle Minét, Françoise Wyers and Raed Ibraheim. Their work appears in journals such as Nature, Cell and Nucleic Acids Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact